There are no studies on quality of life (QoL) in CSF1R-ALSP; however, in other neurodegenerative diseases, cognition was shown to be one of the most important determinants of the QoL of patients and their caregivers [12,13,14]. The gene discussed is CSF1R; the disease is neurodegenerative disease.